Candesartan cilexetil steady-state concentrations are approximately twice as high in haemodialysis recipients

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1402, 2003-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Candesartan Cilexetil in Haemodialysis Patients

By Ottosson P.  

Clinical Drug Investigation, Vol. 23, Iss. 8, 2003-01 ,pp. : 545-550

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis: An Open-Label, Single-Centre Study

By Schulz Egbert G.  

Clinical Drug Investigation, Vol. 29, Iss. 11, 2009-11 ,pp. : 713-719

Adis International

Access to resources Recommend Favorite

QOL in hypertension maintained with candesartan cilexetil

By  

Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

QOL in hypertension maintained with candesartan cilexetil

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 269, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Model to Predict Steady-State Exposure to Once-Daily Cyclosporin Microemulsion in Renal Transplant Recipients

By Schädeli F.   Marti H-P.   Frey F.J.   Uehlinger D.E.  

Clinical Pharmacokinetics, Vol. 41, Iss. 1, 2002-01 ,pp. : 59-69

Adis International

Access to resources Recommend Favorite